JW Pharmaceutical Corporation (001060) Stock Statistics & Valuation Metrics

JW Pharmaceutical Corporation has a market cap or net worth of ₩551.57B. The enterprise value is $716.81K.

JW Pharmaceutical Corporation has 23,285,930 shares outstanding. The number of shares has decreased by -2.65% in one year.

JW Pharmaceutical Corporation’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 14.08%.

The current PE Ratio of JW Pharmaceutical Corporation is 8.2. JW Pharmaceutical Corporation’s PEG ratio is -2.42.

In the last 12 months, JW Pharmaceutical Corporation had revenue of 774.80B and earned 61.69B in profits. Earnings per share was 2.53K.

In the last 12 months, operating cash flow was 85.32B and capital expenditures -22.54B, giving a free cash flow of 62.78B billion.

JW Pharmaceutical Corporation pays an annual dividend of ―, resulting in a dividend yield of ―

JW Pharmaceutical Corporation upcoming earnings date is Aug 18, 2026, TBA (Confirmed).

JW Pharmaceutical Corporation as a current ratio of 1.42, with Debt / Equity ratio of 14.18%

In the past 12 months, JW Pharmaceutical Corporation has paid 27.32B in taxes.

JW Pharmaceutical Corporation EV to EBITDA ratio is 5.92, with an EV/FCF ratio of 7.46.

JW Pharmaceutical Corporation has ₩31.69B in cash and marketable securities with ₩54.12B in debt, giving a net cash position of -₩22.44B billion.

Gross margin is 47.32%, with operating margin of 11.34%, and net profit margin of 7.96%.

The average price target for JW Pharmaceutical Corporation is ―, which is 11.43% higher than the current price. The consensus rating is ―